Literature DB >> 24695700

14-3-3 proteins are required for hippocampal long-term potentiation and associative learning and memory.

Haifa Qiao1, Molly Foote, Kourtney Graham, Yuying Wu, Yi Zhou.   

Abstract

14-3-3 is a family of regulatory proteins highly expressed in the brain. Previous invertebrate studies have demonstrated the importance of 14-3-3 in the regulation of synaptic functions and learning and memory. However, the in vivo role of 14-3-3 in these processes has not been determined using mammalian animal models. Here, we report the behavioral and electrophysiological characterization of a new animal model of 14-3-3 proteins. These transgenic mice, considered to be a 14-3-3 functional knock-out, express a known 14-3-3 inhibitor in various brain regions of different founder lines. We identify a founder-specific impairment in hippocampal-dependent learning and memory tasks, as well as a correlated suppression in long-term synaptic plasticity of the hippocampal synapses. Moreover, hippocampal synaptic NMDA receptor levels are selectively reduced in the transgenic founder line that exhibits both behavioral and synaptic plasticity deficits. Collectively, our findings provide evidence that 14-3-3 is a positive regulator of associative learning and memory at both the behavioral and cellular level.

Entities:  

Keywords:  14-3-3 proteins; NMDA receptors; fear conditioning; long-term potentiation; passive avoidance

Mesh:

Substances:

Year:  2014        PMID: 24695700      PMCID: PMC3972712          DOI: 10.1523/JNEUROSCI.4393-13.2014

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  46 in total

1.  Isolation of high-affinity peptide antagonists of 14-3-3 proteins by phage display.

Authors:  B Wang; H Yang; Y C Liu; T Jelinek; L Zhang; E Ruoslahti; H Fu
Journal:  Biochemistry       Date:  1999-09-21       Impact factor: 3.162

2.  14-3-3 proteins mediate an essential anti-apoptotic signal.

Authors:  S C Masters; H Fu
Journal:  J Biol Chem       Date:  2001-09-27       Impact factor: 5.157

3.  Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216.

Authors:  C Y Peng; P R Graves; R S Thoma; Z Wu; A S Shaw; H Piwnica-Worms
Journal:  Science       Date:  1997-09-05       Impact factor: 47.728

Review 4.  14-3-3 proteins in the nervous system.

Authors:  Daniela Berg; Carsten Holzmann; Olaf Riess
Journal:  Nat Rev Neurosci       Date:  2003-09       Impact factor: 34.870

5.  Adapter protein 14-3-3 is required for a presynaptic form of LTP in the cerebellum.

Authors:  Fatma Simsek-Duran; David J Linden; György Lonart
Journal:  Nat Neurosci       Date:  2004-11-14       Impact factor: 24.884

6.  Hippocampal dysregulation of synaptic plasticity-associated proteins with age-related cognitive decline.

Authors:  Heather D VanGuilder; Julie A Farley; Han Yan; Colleen A Van Kirk; Matthew Mitschelen; William E Sonntag; Willard M Freeman
Journal:  Neurobiol Dis       Date:  2011-04-01       Impact factor: 5.996

7.  Protein kinase C mu is negatively regulated by 14-3-3 signal transduction proteins.

Authors:  A Hausser; P Storz; G Link; H Stoll; Y C Liu; A Altman; K Pfizenmaier; F J Johannes
Journal:  J Biol Chem       Date:  1999-04-02       Impact factor: 5.157

8.  Interaction of 14-3-3 with signaling proteins is mediated by the recognition of phosphoserine.

Authors:  A J Muslin; J W Tanner; P M Allen; A S Shaw
Journal:  Cell       Date:  1996-03-22       Impact factor: 41.582

Review 9.  Overexpression of growth-associated proteins in the neurons of adult transgenic mice.

Authors:  P Caroni
Journal:  J Neurosci Methods       Date:  1997-01       Impact factor: 2.390

10.  Acute in vivo genetic rescue demonstrates that phosphorylation of RIM1alpha serine 413 is not required for mossy fiber long-term potentiation.

Authors:  Ying Yang; Nicole Calakos
Journal:  J Neurosci       Date:  2010-02-17       Impact factor: 6.167

View more
  37 in total

1.  14-3-3 inhibition promotes dopaminergic neuron loss and 14-3-3θ overexpression promotes recovery in the MPTP mouse model of Parkinson's disease.

Authors:  H Ding; R Underwood; N Lavalley; T A Yacoubian
Journal:  Neuroscience       Date:  2015-08-24       Impact factor: 3.590

2.  14-3-3γ binds regulator of G protein signaling 14 (RGS14) at distinct sites to inhibit the RGS14:Gαi-AlF4- signaling complex and RGS14 nuclear localization.

Authors:  Kyle J Gerber; Katherine E Squires; John R Hepler
Journal:  J Biol Chem       Date:  2018-08-09       Impact factor: 5.157

3.  14-3-3 Proteins Reduce Cell-to-Cell Transfer and Propagation of Pathogenic α-Synuclein.

Authors:  Bing Wang; Rachel Underwood; Anjali Kamath; Colleen Britain; Michael B McFerrin; Pamela J McLean; Laura A Volpicelli-Daley; Robert H Whitaker; William J Placzek; Katelyn Becker; Jiyan Ma; Talene A Yacoubian
Journal:  J Neurosci       Date:  2018-08-09       Impact factor: 6.167

4.  Inhibition of 14-3-3 Proteins Leads to Schizophrenia-Related Behavioral Phenotypes and Synaptic Defects in Mice.

Authors:  Molly Foote; Haifa Qiao; Kourtney Graham; Yuying Wu; Yi Zhou
Journal:  Biol Psychiatry       Date:  2015-02-19       Impact factor: 13.382

Review 5.  Peptide regulation of cofilin activity in the CNS: A novel therapeutic approach for treatment of multiple neurological disorders.

Authors:  Alisa E Shaw; James R Bamburg
Journal:  Pharmacol Ther       Date:  2017-02-20       Impact factor: 12.310

6.  Alternative Splicing of Presynaptic Neurexins Differentially Controls Postsynaptic NMDA and AMPA Receptor Responses.

Authors:  Jinye Dai; Jason Aoto; Thomas C Südhof
Journal:  Neuron       Date:  2019-04-17       Impact factor: 17.173

7.  A single phosphorylation site of SIK3 regulates daily sleep amounts and sleep need in mice.

Authors:  Takato Honda; Tomoyuki Fujiyama; Chika Miyoshi; Aya Ikkyu; Noriko Hotta-Hirashima; Satomi Kanno; Seiya Mizuno; Fumihiro Sugiyama; Satoru Takahashi; Hiromasa Funato; Masashi Yanagisawa
Journal:  Proc Natl Acad Sci U S A       Date:  2018-09-25       Impact factor: 11.205

Review 8.  Psychiatric disorders biochemical pathways unraveled by human brain proteomics.

Authors:  Verônica M Saia-Cereda; Juliana S Cassoli; Daniel Martins-de-Souza; Juliana M Nascimento
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2016-07-04       Impact factor: 5.270

9.  14-3-3 Proteins regulate mutant LRRK2 kinase activity and neurite shortening.

Authors:  Nicholas J Lavalley; Sunny R Slone; Huiping Ding; Andrew B West; Talene A Yacoubian
Journal:  Hum Mol Genet       Date:  2015-11-05       Impact factor: 6.150

Review 10.  14-3-3 Proteins: Novel Pharmacological Targets in Neurodegenerative Diseases.

Authors:  F Sanders Pair; Talene A Yacoubian
Journal:  Trends Pharmacol Sci       Date:  2021-01-28       Impact factor: 14.819

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.